London (ots/PRNewswire) - The 13 members of the Organization of the Petroleum Exporting Countries (OPEC) pumped an average 32.81 million barrels per day (b/d) of crude oil in August, a Platts survey of OPEC and oil industry officials showed September 9. This is 40,000 b/d higher than the July production of 32.77 million b/d. Excluding Iraq, the 12 members ...
Heilbronn, Germany (ots/PRNewswire) - Atmel(R) (Nasdaq: ATML) announced today a significant enhancement to the ATA2270-EK1 125-kHz RFID demo kit. This kit, which enables the evaluation and prototyping of Atmel's wide portfolio of LF IDIC(R)s, has been upgraded to include a PC-based GUI application to ...
Bristol-Myers Squibb and AstraZeneca
Rome (ots/PRNewswire) - - FOR EUROPEAN MEDICAL MEDIA ONLY - New Data Presented for the First Time at EASD 2008 - Saxagliptin With Metformin as Initial Combination Therapy Lowered A1C - Improvements Demonstrated Across Key Measures of Glucose Control Studied in Treatment-Naïve People With Type 2 ...
Bristol-Myers Squibb and AstraZeneca
Rome (ots/PRNewswire) - - FOR EUROPEAN MEDICAL MEDIA ONLY - New Data Presented for the First Time at EASD 2008 - Saxagliptin With Metformin as Initial Combination Therapy Lowered A1C - Improvements Demonstrated Across Key Measures of Glucose Control Studied in Treatment-Naïve People With Type 2 ...
Rome (ots/PRNewswire) - - Exciting New Data From the FIELD Study Show Additional Microvascular-Associated Benefits of Fenofibrate - The First Time in a Large-Scale Prospective Study That any Lipid-Modifying Therapy has Been Shown to Significantly Reduce the Risk of Lower-Limb Amputation in Patients With Type 2 Diabetes Fenofibrate treatment in people ...
Rousset, France (ots/PRNewswire) - - AT73C224 Sources 3V to 5V Supplies, Provides Four Regulated Power Supply Channels, Integrates Real Time Clock and Two Wire Interface Atmel(R) Corporation (Nasdaq: ATML) announced today the release of its AT73C224 Analog Companion Power Management Unit designed for a wide range of applications based on 32-bit MCUs. The ...
Paris (ots/PRNewswire) - - The THIN, ROLE and LIVE-DE Studies Used Medical Databases or Medical Records to Compare the Benefits of Different Insulin Treatments in Thousands of People Living With Type 2 Diabetes - Abstracts 1000, 1001 and 1004 Sanofi-aventis, a world leader in diabetes care, announced ...
Rousset, France (ots/PRNewswire) - - Institute of Embedded Systems, Zurich University of Applied Sciences, Personalizes CAP for UWB Applications Atmel(R) Corporation (Nasdaq: ATML) and the Institute of Embedded Systems (InES), Zurich University of Applied Sciences, announced today the availability of an Ultra Wideband (UWB) transceiver that InES has ...
Abbott Park, Illinois (ots/PRNewswire) - - Abbott Only U.S.-based Fortune 100 Health Care Manufacturer to Be Listed on Both North America and World Indexes Abbott (NYSE: ABT), the global health care company, announced today that it was recognized on the Dow Jones Sustainability World Index and the Dow Jones Sustainability North America Index for the fourth ...
Maidenhead, England (ots/PRNewswire) - - Prevenar Vaccine to Help Protect Children Against the Leading Vaccine-Preventable Cause of Death in Young Children Worldwide MAIDENHEAD, England, September 4 /PRNewswire/ -- Wyeth today announced that Cyprus and the Republic of Ireland have initiated national ...
London (ots/PRNewswire) - Doosan Babcock jointly with Doosan Heavy Industries of Korea have announced a Global Technology Licensing Agreement with a leading Canadian CO2 management technology company, HTC Purenergy Inc. ("HTC"). In conjunction with the Licensing Agreement, Doosan Babcock and Doosan Heavy ...
Calgary, Canada (ots/PRNewswire) - - Provides Shareholders With an Update on Strategic Review Activities On behalf of Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) the Board of Directors, due to the recent advancement of various discussions with third parties, feel it is prudent to update the market as to activities surrounding a previously announced strategic review process of January 25, 2007. ...
General Nutrition Centers, Inc.
Pittsburgh (ots/PRNewswire) - General Nutrition Centers, Inc., the largest global specialty retailer of nutritional supplements, today announced another step in its continuing expansion in Europe through an exclusive distribution agreement for online sales of GNC's private label products, its first in Europe, ...
Munich, Germany (ots/PRNewswire) - - In spite of the success of therapies targeting LDL in lowering cardiovascular risk, a residual risk still remains Cardiologists in Europe agree that reducing LDL-cholesterol (LDL-C or "bad" cholesterol) levels is the most important factor in treating dyslipidemia (abnormal blood lipids) and reducing the risk of a ...
Calgary, Canada (ots/PRNewswire) - - Multiple Presentations Included Resverlogix Data - TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to announce that Dr. Norman Wong presented key clinical data pertaining to its lead compound, RVX-208, at the European Society Cardiology (ESC) 2008 Congress in Munich. The presentation titled "RVX-208 a novel small ...
San Jose, California (ots/PRNewswire) - - Facilitates Low-cost, Easy Evaluation of CAP Capabilities Atmel(R) Corporation (Nasdaq: ATML) today announced its AT91CAP7A-STK Starter Kit for the evaluation of its ARM7(TM)-based CAP(TM) family of customizable microcontrollers. CAP7 customizable MCUs allow designers to migrate ARM7-plus-FPGA designs to a ...
Amsterdam (ots/PRNewswire) - Avantium announced today that it has entered into a master services agreement with Chevron Energy Technology Company for the application of high-throughput technologies in the development of catalysts in the oil and gas field. Avantium specializes in high-throughput methodologies that enable scientists to conduct parallel experiments ...
Society for Cardiovascular Angiography and Interventions (SCAI)
Washington (ots/PRNewswire) - - At One Year, Angioplasty and Stenting Matches Bypass Surgery for Safety and Effectiveness in Patients with Complex Medical Condition Patients with both diabetes and advanced blockages in at least three heart vessels will find good news in new findings announced today from the CARDia trial, says The Society for ...
Society for Cardiovascular Angiography and Interventions (SCAI)
Washington (ots/PRNewswire) - - One-Year Data Find Angioplasty and Stenting Safe and Effective in Patients for Whom Standard Therapy Has Been Open-Heart Surgery Data announced today from the landmark SYNTAX trial indicate that patients with very complex coronary artery disease can safely choose to be treated with angioplasty and drug-eluting stents rather ...
Munich, Germany (ots/PRNewswire) - Biosensors International Group, Ltd ("Biosensors", "Company"), (Bloomberg: BIG:SP), (Singapore:B20) today announced that a next-generation drug-eluting stent, developed by Biosensors, has demonstrated equal safety and efficacy as compared to Johnson & Johnson's industry leading ...
Montpellier, France (ots/PRNewswire) - The ERATO study published today in the American Heart Journal demonstrated, for the first time in patients with permanent atrial fibrillation, that dronedarone (Multaq(R)) significantly reduces mean 24 hour ventricular rate, on top of other rate control agents. The mean ...
Munich, Germany (ots/PRNewswire) - - TRANSCEND(R), Parallel Trial to ONTARGET(R), Confirms Long-Term Protective Benefits and Excellent Tolerability Profile of Telmisartan 80mg(1) on Top of Current Best Standard of Care MUNICH, Germany, August 31 /PRNewswire/ -- - For non-US Healthcare Media The ...
Cork, Ireland (ots/PRNewswire) - -INTELENCE is the First NNRTI to Show Antiviral Activity in Patients With NNRTI-Resistant Virus The European Medicines Agency (EMEA) has granted marketing authorisation for the anti-HIV medication INTELENCE(TM) (etravirine). INTELENCE is a next generation non-nucleoside ...
Astellas Pharma Europe Limited
Staines, England (ots/PRNewswire) - - Not for distribution in the United Kingdom - Research Adds to Already Demonstrated Efficacy in Adult Population Parents and paediatricians are today welcoming the results of new research that adds additional support for an effective and well tolerated treatment ...
Washington (ots/PRNewswire) - Crude oil prices "could" fall below US$100 per barrel over the next 18 months on slowing worldwide demand and an increase in oil production, Energy Information Administration (EIA) chief Guy Caruso said Tuesday. Caruso made the comment to reporters at the Platts Energy Podium in Washington. "I think [prices] could fall below US$100 a barrel on slowing global demand and rising ...
Laval, Canada (ots/PRNewswire) - The Laval-based firm Algorithme Pharma is pleased to announce that it has achieved its goal of securing a European facility through its acquisition of Simbec Research Ltd in Merthyr Tydfil, Wales. This news comes only six weeks after confirming the purchase of another clinical ...
Calgary, Canada (ots/PRNewswire) - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) is pleased to announce that the Phase 1b/2a program for the study of RVX-208 in subjects with normal lipids and those with low high-density lipoprotein (HDL) cholesterol has proceeded according to plan. "We are very excited about moving forward into this important 28-day study with RVX-208. Our previous clinical study ...
San Jose, California (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) announced today the production availability of its new AT25DF081, the industry's first 8-megabit Serial Flash device capable of operating at 1.8-volts. With a low-voltage operating range of 1.65V to 1.95V, the AT25DF081 operates at the same voltage range as many current and ...
Abbotsford, British Columbia (ots/PRNewswire) - ICS Copper Systems Ltd. (ICS) (ICX:TSX.V) is pleased to announce the appointment of Mr. Richard Molyneux to the position of Chairman of the Board of Directors. The Company wishes to express its gratitude to the outgoing Chairman, Mr. Mel Smale, who will stay on as a Director. Mr. Smale has been the Chairman of ICS since the Company went public and has served the ...
Indianapolis (ots/PRNewswire) - - Study with duloxetine evaluating long-term pain reduction in treatment of DPNP is first to exceed three months Duloxetine hydrochloride maintained pain reduction in the treatment of diabetic peripheral neuropathic pain (DPNP) for more than six months,(1) according to new ...